Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Articles

Alexandre Juillerat, PhD, innovation senior scientist at Cellectis, discusses novel construct UCART123, an investigational agent that is on deck to be the first gene-edited T-cell product in the United States.

Honing in on the Tumor Microenvironment

The agency recommended approval of a total of eight drugs at its January 2017 meeting, two of which are biosimilars.

EMA Recommends Approval of Two Biosimilars

ADMA will acquire BPC’s plasma-based fractionation and purification plant in Boca Raton, FL and plans to resolve issues at the facility noted in an FDA warning letter.

ADMA Biologics to Acquire Plasma-Based Biologics Facility from Biotest

SGS invested in test equipment for analyzing extractables and leachables at its New Jersey laboratory.

SGS Expands Extractables and Leachables Testing

Vetter expanded visual inspection facilities and controlled-temperature storage at its Ravensburg Vetter West facility in Germany.

Vetter Starts Operations in Its Center for Visual Inspection and Logistics

Researchers from Cellectis investigate how external signals in the tumor microenvironment could control the cell-surface expression and specificity of engineered CARs.

Cellectis Describes Novel CAR-T Design in New Paper

Merck will pay a one-time fee of $625 million and additional royalties to BMS and Ono Pharmaceutical to settle the patent infringement case related to Keytruda.

Merck Settles Litigation with Bristol-Myers Squibb on Use of Antibody Targeting PD-1

Camfil Air Pollution Control has expanded its testing laboratory and added a dust collection test rig for the ANSI dust collection standard.

Camfil APC Expands Laboratory for Testing Dust Collection Systems

EAG Laboratories offers dermal absorption studies using OECD methods.

EAG Laboratories Adds Capabilities in Dermal Absorption Testing

Researchers were not able to replicate all of the findings in five highly-cited cancer biology papers.